Cernostics Secures Additional Patents for Proprietary Barrett’s Esophagus Clinical Diagnostics
– US and EU patents for TissueCypher® cover methods for detecting risk of progression to esophageal cancer in Barrett’s esophagus patients – PITTSBURGH, Penn., November 20, 2018 — Cernostics, developer of next-generation cancer dia...
Read more
